Buscar
Mostrando ítems 1-10 de 397
Determination of susceptibility to sensitization to dental materials in atopic and non-atopic patients
(MEDICINA ORAL S L, 2012-03)
Introduction: Some studies report that atopic patients have a greater frequency of delayed-type sensitization than non-atopic patients.
Objective: To determine the influence of the atopic condition on delayed sensitization ...
Healthcare disparities in atopic dermatitis in Latin America: A narrative review
(2022)
Introduction: Atopic dermatitis (AD) is a chronic, pruritic skin disease caused by a mixture of genetic, immunological, and environmental factors, characterized by periods of inflammation and remission. In Latin America ...
Atopic dermatitis and vitamin D: facts and controversies
(Soc Brasileira Dermatologia, 2013-11-01)
Patients with atopic dermatitis have genetically determined risk factors that affect the barrier function of the skin and immune responses that interact with environmental factors. Clinically, this results in an intensely ...
Evaluate of the efficacy and safety of tacrolimus ointment 0,03% to treat atopic dermatitis in pediatric patients
(SOC BRASILEIRA DERMATOLOGIA, 2008)
BACKGROUND: Tacrolimus ointment has been shown to be effective in treatment of atopic dermatitis. OBJECTIVES: To evaluate the efficacy and safety of 0.03% tacrolimus ointment (Protopic(R)) in pediatric patients with mild, ...
Clinical and Immunological Changes of Immunotherapy in Patients with Atopic Dermatitis: Randomized Controlled Trial
(HindawiGrupo de Alergología Clínica y Experimental (GACE)Nueva York, Estados Unidos, 2022)
Estudo da correlação entre molusco contagioso e dermatite atópica em crianças
(Sociedade Brasileira de Dermatologia, 2011-08-01)
BACKGROUND: Although no scientific evidence has yet been published, it is widely understood that molluscum contagiosum tends to be more common and more intense in patients with atopic dermatitis. This lack of evidence led ...
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: results from the JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN phase 3 trial
(Elsevier, 2022)
Background: The heterogeneous course of moderate-to-severe atopic dermatitis necessitates treatment flexibility.
Objective: We evaluated the maintenance of abrocitinib-induced response with continuous abrocitinib ...
Atopic dermatitis in adults: evaluation of peripheral blood mononuclear cells proliferation response to Staphylococcus aureus enterotoxins A and B and analysis of interleukin-18 secretion
(WILEY-BLACKWELL PUBLISHING, INC, 2009)
Atopic dermatitis (AD) is a chronic, inflammatory skin disease with a high prevalence and complex pathogenesis. The skin of AD patients is usually colonized by Staphylococcus aureus (S. aureus); its exotoxins may trigger ...